Development of an Institutional Knowledge-base at FDA’s Center for Food Safety and Applied Nutrition Kirk B. Arvidson 1, Annette McCarthy 1, Chihae Yang.

Slides:



Advertisements
Similar presentations
Perspectives from EPA’s Endocrine Disruptor Screening Program
Advertisements

Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
Carcinogen Classification Criteria Patricia Richter Ph.D., DABT Tobacco Products Scientific Advisory Committee June 8, 2010.
National Pesticide Program A New Toxicology Testing Paradigm: Meeting Common Needs Steven Bradbury, Director Environmental Fate and Effects Division Office.
© 2005 by Nelson, a division of Thomson Canada Limited. 1 Consumer Stakeholders: Product and Service Issues Search the Web The American Society for Quality.
1 Development & Evaluation of Ecotoxicity Predictive Tools EPA Development Team Regional Stakeholder Meetings January 11-22, 2010.
Use of Threshold of Concern in determining data requirements for the evaluation of tobacco ingredients Richard A. Ford. Ph.D. International Aroma Chemical.
Chemical Category Formation: Toxicology and REACH Dr Steven Enoch Liverpool John Moores University 14 th May 2009.
Current Perspectives on Biotechnology: Projects and Future Challenges/Opportunities Jordan BeanDr. Jaimie Schnell Novel Foods SectionPlant Health and Biotechnology.
Office of Research and Development National Center for Computational Toxicology April 6, 2010 Exposure-Based Chemical Prioritization Workshop: Exploring.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
What Do Toxicologists Do?
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Food Safety Assessment Kevin Greenlees, PhD, DABT Kathleen Jones, PhD.
FDA’s Policy for Evaluating Bioengineered Foods Jeanette Glover Glew Food and Drug Administration Center For Food Safety and Applied Nutrition September,
Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.
DSHEA and Bioavailability Elizabeth A. Yetley, Ph.D. Ctr. Food Safety & Applied Nutrition Food and Drug Administration.
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
Predicting human dose-response relationships from multiple biological models: Issues with Cryptosporidium parvum Risk Assessment Consortium.
Application of Toxicology Databases in Drug Development (Estimating potential toxicity) Joseph F. Contrera, Ph.D. Director, Regulatory Research and Analysis.
1 The Discovery Informatics Framework Pat Rougeau President and CEO MDL Information Systems, Inc. Delivering the Integration Promise American Chemical.
Biotech Food ‘safety and beyond’ Jeanine A. G. van de Wiel Health Council of the Netherlands Committee on Safety Assessment of Novel Foods
CVM’s Procedure for Setting Tolerances
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Office of Research and Development Photo image area measures 1.5” H x 7” and can be masked by a collage strip of one, two or three images. The photo image.
REGULATORY CHALLENGES FOR NANOMATERIALS IN PUBLIC HEALTH Driving Faster Than Our Nano-Headlights AAAS Annual Meeting February 13, 2009 Norris E. Alderson,
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Reproductive Health Drugs, Pregnancy Labeling Subcommittee Meeting March 28-29, 2000 Holli A. Hamilton, M.D., M.P.H. Pregnancy Labeling Team Office of.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
1 Innovative Science To Improve Public Health EDKB: Endocrine Disruptors Knowledge Base at the FDA Huixiao Hong, Ph.D. Center for Bioinformatics Division.
Mike Comber Consulting TIMES-SS Assessment of skin sensitisation hazard Presented on behalf of the TIMES-SS consortia.
Forging Partnerships on Emerging Contaminants November 2, 2005 John Vandenberg Associate Director for Health National Center for Environmental Assessment.
Furan in Food Summary and Charge to the FAC and SCNT Terry C. Troxell, Ph.D. Director Office of Plant and Dairy Foods FDA Center for Food Safety and Applied.
Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Office of Research and Development.
Council for Responsible Nutrition FDA Public Meeting on New Dietary Ingredients Annette Dickinson, Ph.D. November 15, 2004.
Major Components of FDA’s Action Plan for Acrylamide Richard Canady, PhD DABT US Food and Drug Administration Center for Food Safety and Applied Nutrition.
Lhasa ICH M7 Database – Use Cases Dr Angela White.
Mike Comber TIMES-SS Application of Reactivity Principles in Screening for Skin Sensitisers Presented on behalf of the TIMES-SS consortia & International.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
Background on Furan in Foods Nega Beru, Ph.D. Director, Division of Plant Product Safety Office of Plant and Dairy Foods Center for Food and Applied Nutrition.
December 2006Characterizing Chemicals in Commerce 1 Using the EPA HPVIS to Form Chemical Categories for Hazard Assessment Sandra Reiss Murphy, PhD Arkema.
Regulatory Chemical Risk Assessment From Superfund to Contaminants of Emerging Concern Where Have We Been and Where Are We Going? Patrick Gwinn November.
Barcelona April, 2008 Overview of the QSAR Application Toolbox Gilman Veith International QSAR Foundation Duluth, Minnesota.
1 Drug Safety Oversight Board: Recent Activities FDA Science Board Advisory Committee Meeting March 31 st, 2006 Douglas C. Throckmorton, MD Deputy Director.
Use of Machine Learning in Chemoinformatics
Awareness Training: ‘HARPC’ for Food Safety Complimentary Presentation by Quality Systems Enhancement 1790 Wood Stock Road Roswell GA E. mail:
Call for ANS & CEF Panel Members. Make a difference to European Food Safety – Join EFSA’s Scientific Panels!
Summation of Toxicity Data in Vitic Andrew Thresher
Strategies to build toxicity databases for data mining Chihae Yang June 28, 2007 Leadscope, inc.
QSAR Application Toolbox: First Steps - Data Gap Filling (Read-Across by Analogue Approach)
Who is NCCT? National Center for Computational Toxicology – part of EPA’s Office of Research and Development Research driven by EPA’s Chemical Safety for.
General Concepts in QSAR for Using the QSAR Application Toolbox
Patient Focused Drug Development An FDA Perspective
QSAR Application Toolbox: Step 12: Building a QSAR model
Using Derek Nexus to assess the safety of raw materials used in cosmetics and as part of a skin sensitisation ITS. Part 1: Using Derek Nexus to assess.
Jeff Shuren, MD, JD Center for Devices and Radiological Health U. S
FDA Perspective on Cardiovascular Device Development
COSMOS DB as an international share point for exchanging regulatory and toxicity data of cosmetics ingredients and related substances C Yang1,2, DP Hristozov1,
General Concepts in QSAR for Using the QSAR Application Toolbox
Background This is a step-by-step presentation designed to take the first time user of the Toolbox through the workflow of a data filling exercise.
Decision Contexts in a Changing Toxicology Paradigm
Food Product Name Name(s).
Regulatory Sciences and Government Affairs
Evaluating alert performance accounting for a metabolism
IDEA International Dialogue for the Evaluation of Allergens
EFSA’s Chemical Hazards Database
Introduction to Risk Assessment
Presentation transcript:

Development of an Institutional Knowledge-base at FDA’s Center for Food Safety and Applied Nutrition Kirk B. Arvidson 1, Annette McCarthy 1, Chihae Yang 2, Dimitar Hristozov 1 1)U.S. Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN) Office of Food Additive Safety (OFAS) 2) The Ohio State University, Columbus, Ohio

Outline Introduction CERES workflow Database scheme Query Results QSAR models Q&A

Office Of Food Additive Safety (OFAS) OFAS is a program office within CFSAN –Ensure the safety of food additives and packaging in U.S. Evaluate safety information in industry submissions for various categories of food ingredients –Direct food additives (e.g., high intensity sweeteners) –Biotech foods (e.g., herbicide-ready soybeans) –Generally Recognized as Safe (GRAS – phosphoric acid) –Food contact substances (e.g., plastic bottles, sanitizers)

Pre- and Post-market Evaluations Shortfall of current processes –Rely on institutional knowledge –Data is sequestered in multiple small databases –Accessing/locating data can be difficult and time consuming –Difficult to keep data up to date-time and resource intensive –No systematic method to bring together disparate tox. data on a compound or its structural and biological analogues Current needs –A centralized knowledgebase accessible from desktop computer –Real time access to data-both internal and external sources –Relate new and existing data in new ways –Leveraging knowledge more efficiently –Make sound decisions faster

Chemical Evaluation and Risk Estimation System (CERES) Food additives knowledge-base –Captures institutional knowledge –Chemical centric –Structured data/controlled vocabulary Desktop access to: –Internal and external chemical and toxicity data –Structure analog searching and data retrieval –QSAR Models –Threshold of Toxicological Concern evaluations

CERES Workflow Decision Support for Safety Assessment Pre-market Safety Decisions Post-market Safety Decisions Post-market Review Portal Pre-market Review Portal Submission Data Literature Data Computational Toxicology Read-across Rule-base Mode of action models Threshold of toxicological concern (TTC) Safety Alert Knowledgebase Results Set Decision Support for Safety Assessment Pre-market Safety Decisions Post-market Safety Decisions Post-market Review Portal Pre-market Review Portal Submission Data Literature Data Computational Toxicology Read-across Rule-base Mode of action models Threshold of toxicological concern (TTC) Safety Alert Knowledgebase Results Set Decision Support for Safety Assessment Pre-market Safety Decisions Post-market Safety Decisions Post-market Review Portal Pre-market Review Portal Submission Data Literature Data Computational Toxicology Read-across Rule-base Mode of action models Threshold of toxicological concern (TTC) Safety Alert Knowledgebase Results Set Decision Support for Safety Assessment Pre-market Safety Decisions Post-market Safety Decisions Post-market Review Portal Pre-market Review Portal Submission Data Literature Data Computational Toxicology Read-across Rule-base Mode of action models Threshold of toxicological concern (TTC) Safety Alert Knowledgebase Results Set Decision Support for Safety Assessment Pre-market Safety Decisions Post-market Safety Decisions Post-market Review Portal Pre-market Review Portal Submission Data Literature Data Computational Toxicology Read-across Rule-base Mode of action models Threshold of toxicological concern (TTC) Safety Alert Knowledgebase Results Set Decision Support for Safety Assessment Pre-market Safety Decisions Post-market Safety Decisions Post-market Review Portal Pre-market Review Portal Submission Data Literature Data Computational Toxicology Read-across Rule-base Mode of action models Threshold of toxicological concern (TTC) Safety Alert Knowledgebase Results Set

Simplified Database Scheme

Query Page

Query Results: Regulatory Summary

Query Results: Study Summary

Prediction Models

Weight of evidence and mode of action models MoA classes Aldehydes PhenolsAromatic AminesAlkyl halides Global Not likely mutagenic Categories Likely mutagenic.... Alerts NH 2 OH Weight of evidence averaging 0.588

Enhance Pre-, Post-market Evaluation of Food Ingredients Through Threshold of Toxicological Concern Approach TTC values Repro-Green Dev.-Blue Carc.-Red ????-Grey TTC Values Database Structure Categories

Enhance Pre-, Post-market Evaluation of Food Ingredients Repro-Green Dev.-Blue Carc.-Red ????-Grey Structure Categories Regulatory Action Additional Data Needs Exposure TTC values Query

Chemical Classes concern factor Red: high concern Yellow: intermediate Green: low concern Profiling Toxicological Concerns With Chemical and Biological Classes Biological endpoints

Computational Toxicology Paradigm

ToxCast TM and Tox21 Molecular signatures – biology/chemistry High Throughput Screening assays (>500) – cell-based assays – cell-free target-based assays Leverage legacy toxicity data toxicity bioassays Navigation through chemical classes Red: high corr.; Blue: low corr.

Conclusion CERES –Improve Pre- and Post-Market Review Consolidates information on chemical structure, physical properties and toxicity data to allow for more robust safety analysis Semi-automated monitoring of new safety data relative to authorized chemicals through the use of computational toxicology and TTC –Relate new and existing data in new ways Seek biologically meaningful analogs to fill the data gaps found in many food ingredients and food contact substances Provide molecular level mechanistic insights that eventually help us understand human effects Metabolism knowledge will also be incorporated.